contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-investor-webinar-featuring-antony-hall-how-new-cst-evidence-and-uk-dementia-care-quality-focus-underscore-the-relevance-and-potential-of-ayla

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Brain+ are a pharmaceutical company. The company specializes in research and development for the treatment of dementia and Alzheimer's. The product portfolio includes, for example, cognitive stimulation therapy. In addition to the main business, service and associated ancillary services are also offered. The business is run with the largest presence in Europe. Brain+ is headquartered in Copenhagen.

Brain+

INVESTOR NEWS Copenhagen, Denmark, 6 June 2025 – Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S (“Brain+” or the “Company”) is hosting a webinar on Tuesday, 10 June 2025 at 13:00 CEST / 12...

INVESTOR NEWS&nbsp;Copenhagen, Denmark, 6 June 2025 – Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S (“Brain+” or the “Company”) is hosting a webinar on Tuesday, 10 June 2025 at 13:00 CEST / 12:00 UK time. <a href="https://eur05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fapp.stokk.io%2Fapp%2Fbrain%2Fevent%2F213%2Finvestor-update%2F&amp;data=05%7C02%7Channe%40brain-plus.com%7C1cbee89d5de546eaf02608dda5037d39%7Cf2f9babfec61480d81d3c163d28ca06a%7C0%7C0%7C638848156591047256%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=q0D26v30yohDGnP76hrefrZlOtdq%2BUiuQPsmMsdNMJY%3D&amp;reserved=0">Link to the webinar</a>. The webinar will feature Antony Hall, former lead inspector for the UK Quality Care Commission (CQC) and newly joined Brain+ advisor. The webinar will spotlight how Cognitive Stimulation Therapy (CST), delivered through Brain+’ Ayla platform, can effectively support dementia care providers in meeting the CQC’s new quality statements and regulatory expectations.Brain+ is inviting its shareholders, other investors and stakeholders to a live webinar, which will take place on Tuesday, 10 June 2025 at 13:00 CEST / 12:00 UK time. The webinar will be focused on the following topics:<ul><li>Antony Hall, Brain+ advisor and former lead inspector for the Care Quality Commission (CQC) in England, will share insights on how new research reinforces the importance and broader potential of Cognitive Stimulation Therapy (CST) in delivering meaningful, measurable care for people with dementia. Antony will also explain how Brain+’ flagship dementia care product, Ayla – your CST Assistant, can help care homes comply with the quality measures under CQC’s Single Assessment Framework.</li></ul><ul><li>CEO Devika Wood&nbsp;alongside&nbsp;SVP of Partnerships Fiona Costello, will give an update on the recent progress of UK commercial activities, including newly signed UK care home partnership agreements, and provide a status on the near-term sales outlook and the value of current customer leads across the two targeted dementia care market segments: UK private care and residential homes and public memory service units under the NHS.</li></ul>&nbsp;Interested participants can sign up and ask questions in advance via the following link:<a href="https://eur05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fapp.stokk.io%2Fapp%2Fbrain%2Fevent%2F213%2Finvestor-update%2F&amp;data=05%7C02%7Channe%40brain-plus.com%7C1cbee89d5de546eaf02608dda5037d39%7Cf2f9babfec61480d81d3c163d28ca06a%7C0%7C0%7C638848156591047256%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=q0D26v30yohDGnP76hrefrZlOtdq%2BUiuQPsmMsdNMJY%3D&amp;reserved=0">Brain+ webinar: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla</a>The webinar can also be accessed via the event calendar page in the Investor section of Brain+’ website: <a href="https://www.brain-plus.com/investors/event-calendar/">Event Calendar - Brain+</a>A replay of the webinar will be available on Stokk.io&nbsp;via the same link and on the Brain+’ website following the event.&nbsp;Contact InformationCEO, Devika Wood: + 44&nbsp;7429 280366,&nbsp;<a href="mailto:devika@brain-plus.com">devika@brain-plus.com</a>CFO, Hanne Vissing Leth:&nbsp;+45 53 88 99 02,&nbsp;<a href="mailto:hanne@brain-plus.com">hanne@brain-plus.com</a>&nbsp;Brain+ vision:&nbsp;Building the world’s first scalable dementia care platform to help people affected by dementia, live better lives. <div> <hr> <div>Attachments</div> <div><a href="https://storage.googleapis.com/inderes-widgets-prod-assets/brainplus/attachments/d82e804e-3458-4fed-b603-620b6966ad02/2025-0606-b-investor-news-webinar-w-antony-hall.pdf">2025-0606 B Investor News_Webinar w Antony Hall.pdf</a></div> </div>

Invitation to investor webinar featuring Antony Hall: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla